Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Gastrointestinal Stromal Tumor
Drug:
Iclusig (ponatinib)
(
Multi-tyrosine kinase inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
03/13/2023
Excerpt:
Gastrointestinal Stromal Tumorsā¦.Systemic Therapy Agents and Regimens for Unresectable, Progressive or Metastatic Diseaseā¦.Ponatinib, Useful in certain circumstances
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login